Paysign Q1 revenue $8.2M (+31% YoY), net loss $0.3M; reaffirms FY2022 guidance

Paysign, Inc.

2022-Q1 EPS reported -$0.01 revenue$8,220,639

Revenue $8.2M vs $6.3M in Q1 2021; net loss $0.3M (($0.01) per share).
Plasma revenue up 37% to $7.4M; added 9 new centers, exiting with 375 total.
Pharma revenue down 9% to $0.8M; launched 4 new copay programs during quarter.
Adjusted EBITDA positive at $0.9M ($0.02/share) vs negative in Q1 2021.
FY2022 outlook unchanged: revenue $35.25M-$38.35M, adj. EBITDA at least $4.0M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.